Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma

International Journal of Oncology

Volumn 41, Issue 6, 2012, Pages 2038-2046

  Oh, Eun Kyeong ^a   Kim, Yong Wan ^b   Kim, In Wook ^b   Liu, Hai Bo ^b   Lee, Keun Ho ^a   Chun, Heung Jae ^a   Park, Dong Choon ^a   Oh, Eun Jee ^a   Lee, Ah Won ^a   Bae, Su Mi ^b   Ahn, Woong Shick ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Array based comparative genomic hybridization; Cervical intraepithelial neoplasia; Differential DNA copy number aberration; Human papillomavirus; Squamous cell carcinoma

Indexed keywords

ADULT; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CERVICAL INTRAEPITHELIAL NEOPLASIA 1; CERVICAL INTRAEPITHELIAL NEOPLASIA 2; CERVICAL INTRAEPITHELIAL NEOPLASIA 3; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 16P; CHROMOSOME 1Q; CHROMOSOME 2P; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84869760558     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1644     Document Type: Article

References (41)

1. Green J, Berrington de Gonzalez A, Sweetland S, et al: Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 89: 2078-2086, 2003. (Pubitemid 38030906)
2. Pisani P, Bray F and Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97: 72-81, 2002.
3. Termini L, Maciag PC, Soares FA, et al: Analysis of human kallikrein 7 expression as a potential biomarker in cervical neoplasia. Int J Cancer 127: 485-490, 2010.
4. Lockwood WW, Coe BP, Williams AC, MacAulay C and Lam WL: Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines. Int J Cancer 120: 436-443, 2007. (Pubitemid 44956858)
5. Heselmeyer K, Schrock E, du Manoir S, et al: Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93: 479-484, 1996. (Pubitemid 26038181)
6. Rapp L and Chen JJ: The papillomavirus E6 proteins. Biochim Biophys Acta 1378: F1-19, 1998.
7. Hillemanns P, Wang X, Staehle S, Michels W and Dannecker C: Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol 100: 271-275, 2006. (Pubitemid 43075260)
8. Tranbaloc P: [Natural history of precursor lesions of cervical cancer]. Gynecol Obstet Fertil 36: 650-655, 2008 (In French).
9. Wilting SM, Steenbergen RD, Tijssen M, et al: Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas. Cancer Res 69: 647-655, 2009.
10. Ueda Y, Enomoto T, Miyatake T, et al: Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab Invest 83: 1517-1527, 2003. (Pubitemid 37267835)
11. van Zeeburg HJ, Snijders PJ, Pals G, et al: Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. Cancer Res 65: 1271-1276, 2005. (Pubitemid 40270153)
12. van der Laan MJ, Dudoit S and Pollard KS: Augmentation procedures for control of the generalized family-wise error rate and tail probabilities for the proportion of false positives. Stat Appl Genet Mol Biol 3: Jun 15, 2004 (Epub ahead of print).
13. Fitzpatrick MA, Funk MC, Gius D, et al: Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data. Gynecol Oncol 103: 458-462, 2006. (Pubitemid 44602151)
14. Zhai Y, Kuick R, Nan B, et al: Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 67: 10163-10172, 2007. (Pubitemid 350070788)
15. Alazawi W, Pett M, Strauss S, et al: Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. Br J Cancer 91: 2063-2070, 2004. (Pubitemid 40128773)
16. Kang JU, Koo SH, Kwon KC, Park JW and Kim JM: Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer 9: 237, 2009.
17. Milde T, Oehme I, Korshunov A, et al: HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin Cancer Res 16: 3240-3252, 2010.
18. Yang Q, Jie Z, Cao H, et al: Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis 32: 713-722, 2011.
19. Matsuura M, Onimaru M, Yonemitsu Y, et al: Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. Am J Pathol 175: 1709-1721, 2009.
20. Habuchi H, Miyake G, Nogami K, et al: Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and properties. Biochem J 371: 131-142, 2003. (Pubitemid 36458087)
21. Narayan G, Pulido HA, Koul S, et al: Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene 22: 3489-3499, 2003. (Pubitemid 36713747)
22. Rao PH, Arias-Pulido H, Lu XY, et al: Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 4: 5, 2004.
23. Zimmerman ES, Chen J, Andersen JL, et al: Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation. Mol Cell Biol 24: 9286-9294, 2004. (Pubitemid 39391667)
24. Liang M, Ueno M, Oomizu S, et al: Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma. J Cancer Res Clin Oncol 134: 899-907, 2008.
25. Tan GC, Sharifah NA, Shiran MS, Salwati S, Hatta AZ and Paul-Ng HO: Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix. Asian Pac J Cancer Prev 9: 781-784, 2008.
26. Tonk VS, Wilson GN, Yatsenko SA, et al: Molecular cytogenetic characterization of a familial der(1)del(1)(p36.33)dup(1) (p36.33p36.22) with variable phenotype. Am J Med Genet A 139A: 136-140, 2005. (Pubitemid 46211250)
27. Chen M, Ye Y, Yang H, et al: Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer 125: 2342-2348, 2009.
28. Heilstedt HA, Ballif BC, Howard LA, Kashork CD and Shaffer LG: Population data suggest that deletions of 1p36 are a relatively common chromosome abnormality. Clin Genet 64: 310-316, 2003. (Pubitemid 37236131)
29. Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP and Lam WL: Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes Chromosomes Cancer 39: 93-98, 2004. (Pubitemid 37475258)
30. Schlaepfer DD and Mitra SK: Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14: 92-101, 2004. (Pubitemid 38167483)
31. Luo M, Fan H, Nagy T, et al: Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res 69: 466-474, 2009.
32. Ohkuni T, Kojima T, Ogasawara N, et al: Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitro. Med Mol Morphol 42: 204-211, 2009.
33. Benedicto I, Molina-Jimenez F, Bartosch B, et al: The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J Virol 83: 8012-8020, 2009.
34. Li W, Wang W, Si M, et al: The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. J Cancer Res Clin Oncol 134: 1355-1361, 2008.
35. Singh RK, Dasgupta S, Bhattacharya N, et al: Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma. J Cancer Res Clin Oncol 131: 395-406, 2005. (Pubitemid 40674625)
36. Gallego MI, Schoenmakers EF, van de Ven WJ and Lazo PA: Complex genomic rearrangement within the 12q15 multiple aberration region induced by integrated human papillomavirus 18 in a cervical carcinoma cell line. Mol Carcinog 19: 114-121, 1997. (Pubitemid 27296742)
37. Lazo PA: The molecular genetics of cervical carcinoma. Br J Cancer 80: 2008-2018, 1999.
38. Reuter S, Bartelmann M, Vogt M, et al: APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/ POZ-zinc finger protein with growth inhibitory activity. EMBO J 17: 215-222, 1998. (Pubitemid 28041062)
39. Thorland EC, Myers SL, Gostout BS and Smith DI: Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22: 1225-1237, 2003. (Pubitemid 36363386)
40. Pollack JR, Sorlie T, Perou CM, et al: Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99: 12963-12968, 2002.
41. Hyman E, Kauraniemi P, Hautaniemi S, et al: Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62: 6240-6245, 2002. (Pubitemid 35244477)